These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8677644)

  • 41. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

  • 42. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
    Vakhrushev IaM; Loshchakova OIu
    Eksp Klin Gastroenterol; 2007; (1):60-3, 71. PubMed ID: 17547116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NSAIDs and peptic ulcers.
    BMJ; 1990 Mar; 300(6727):814-6. PubMed ID: 2322751
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevention of gastroduodenal injury induced by NSAIDs with low-dose misoprostol.
    Medina Santillán R; Reyes García G; Mateos García E
    Proc West Pharmacol Soc; 1999; 42():33-4. PubMed ID: 10697681
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapy of NSAIDs-induced gastropathy.
    La Corte R; Caselli M; Ruina M; Bajocchi G; Alvisi V; Trotta F
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():37-41. PubMed ID: 9032582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment.
    Lee OY; Kang DH; Lee DH; Chung IK; Jang JY; Kim JI; Cho JW; Rew JS; Lee KM; Kim KO; Choi MG; Lee SW; Lee ST; Kim TO; Shin YW; Seol SY
    Arch Pharm Res; 2014 Oct; 37(10):1308-16. PubMed ID: 24871787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
    Bakowsky VS; Hanly JG
    J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
    MMW Fortschr Med; 2004 Mar; 146(13):61. PubMed ID: 15219139
    [No Abstract]   [Full Text] [Related]  

  • 50. [Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment].
    Karateev AE; Murav'ev IuV
    Klin Med (Mosk); 2001; 79(5):48-50. PubMed ID: 11510188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Is misoprostol effective in NSAID-induced gastrointestinal complications?].
    Stucki G; Sangha O; Michel BA
    Schweiz Med Wochenschr; 1996 Sep; 126(37):1573-8. PubMed ID: 8927962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New approach to the treatment and prophylaxis of NSAID-induced gastropathies in ambulatory practics].
    Burkov SG; Arutiunov AT; Nikiforov PA
    Eksp Klin Gastroenterol; 2007; (5):96-102. PubMed ID: 18389605
    [No Abstract]   [Full Text] [Related]  

  • 53. Misoprostol in patients taking non-steroidal anti-inflammatory drugs.
    Maiden N; Madhok R
    BMJ; 1995 Dec; 311(7019):1518-9. PubMed ID: 8520380
    [No Abstract]   [Full Text] [Related]  

  • 54. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Critical evaluation of economic analysis exemplified by preventive misoprostol administration in antirheumatic drug-induced gastropathy].
    Stucki G; Sangha O
    Z Rheumatol; 1994; 53(1):37-45. PubMed ID: 8165876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [How to reduce the risks of NSAIDs].
    Gross M
    MMW Fortschr Med; 2008 Jul; 150(28-31):50-3; quiz 54. PubMed ID: 19006892
    [No Abstract]   [Full Text] [Related]  

  • 57. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
    Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
    J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rioprostil: a new prostaglandin for treatment of peptic ulcer disease and NSAID-induced digestive lesions. Proceedings of an international symposium. Wiesbaden, 11-13 June 1987.
    Scand J Gastroenterol Suppl; 1989; 164():1-253. PubMed ID: 2510250
    [No Abstract]   [Full Text] [Related]  

  • 59. Omeprazole and bleeding peptic ulcer, or "how case-control studies can tell you what you suspected all along".
    Hawkey CJ
    Epidemiology; 1999 May; 10(3):211-3. PubMed ID: 10230826
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevention of NSAID-induced ulcers.
    Lawless C; Force RW
    J Fam Pract; 1996 Sep; 43(3):239-40. PubMed ID: 8797749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.